Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>Scavenger receptor class A, member 3 (<i>Scara3</i>) was involved in adipogenesis. However, the effect of <i>Scara3</i> on the switch between osteogenesis and adipogenesis of bone marrow mesenchymal stem cells (BMSCs) remains elusive. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Materials and Methods</h3><p>The correlations between <i>SCARA3</i> with the osteogenic-related were analysed based on the GTEx database. The effects of <i>Scara3</i> on osteogenic or adipogenic differentiation of BMSCs were evaluated by qPCR, Western blot (WB) and cell staining. The mechanisms of <i>Scara3</i> regulating Foxo1 and autophagy were validated by co-expression analysis, WB and immunofluorescence. In vivo, <i>Scara3</i> adeno-associated virus was injected into intra-bone marrow of the aged mice and ovariectomized (OVX) mice whose phenotypes were confirmed by micro-CT, calcein double labelling and immunochemistry (HE and OCN staining). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p><i>SCARA3</i> was positively correlated with osteogenic-related genes. <i>Scara3</i> expression gradually decreased during adipogenesis but increased during osteogenesis. Moreover, the deletion of <i>Scara3</i> favoured adipogenesis over osteogenesis, whereas overexpression of <i>Scara3</i> significantly enhanced the osteogenesis at the expense of adipogenesis. Mechanistically, <i>Scara3</i> controlled the cell fate by promoting Foxo1 expression and autophagy flux. In vivo, <i>Scara3</i> promoted bone formation and reduced bone marrow fat accumulation in OVX mice. In the aged mice, <i>Scara3</i> overexpression alleviated bone loss as well. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>This study suggested that <i>Scara3</i> regulated the switch between adipocyte and osteoblast differentiation, which represented a potential therapeutic target for bone loss and osteoporosis. </p></section>

Scara3 regulates bone marrow mesenchymal stem cell fate switch between osteoblasts and adipocytes by promoting Foxo1